ストックスクリーナーアプリを入手
23.83
2.63%
0.61
アフターアワーズ：
23.96
0.13
+0.55%
前日終値:
$23.22
開ける：
$23.33
24時間の取引高:
2.64M
Relative Volume:
1.25
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+5.16%
1か月 パフォーマンス:
-1.00%
6か月 パフォーマンス:
-9.36%
1年 パフォーマンス:
-13.66%
1日の値動き範囲:
$23.02
$24.00
1週間の範囲:
$22.27
$24.00
52週間の値動き範囲:
$22.27
$34.37
ARK Genomic Revolution ETF Stock (ARKG) Company Profile
ARKG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| ARKG | 23.83 | 0 | 0 | 0 | 0 | 0.00 |
| VTI | 296.51 | 417.53B | 0 | 0 | 0 | 0.00 |
| SPY | 595.51 | 372.57B | 0 | 0 | 0 | 0.00 |
| IVV | 598.45 | 253.41B | 0 | 0 | 0 | 0.00 |
| VB | 257.73 | 160.59B | 0 | 0 | 0 | 0.00 |
| QQQ | 505.79 | 124.43B | 0 | 0 | 0 | 0.00 |
ARK Genomic Revolution ETF (ARKG) 最新ニュース
How To Trade (ARKG) - Stock Traders Daily
ARKK's holdings ranked by SA Quant Grades - MSN
Cathie Wood Keeps Betting On Amazon's 'Haul' Play: Ark Loads Up $6M Worth Of Shares - Benzinga
Unusually active option classes on open November 14th - TipRanks
5 Biggest Biotechnology ETFs in 2024 - Nasdaq
6 Stocks Cathie Wood is Buying | Investing - U.S News & World Report Money
Bullish Two Hundred Day Moving Average CrossARKG - Nasdaq
Thematic Portfolios Re-optimisation – Capturing Emerging Trends and Maximising Growth Potential - Syfe
Cathie Wood's ARK ETF Trades Amazon, Mercadolibre Stock By Investing.com - Investing.com Nigeria
Cathie Wood's ARK ETF Trades Amazon, Mercadolibre Stock - Investing.com
Cathie Wood Biotech Offers New Buy Point - Investor's Business Daily
Cathie Wood's Wednesday Exodus: Moderna And Jack Dorsey's Block Stocks Get Dumped - Benzinga
Cathie Wood positions for new tech boomand it doesn’t matter who wins the White House - CNBC
Crispr, Intellia, and Recursion gain as Ark ETFs boost stakes - MSN
When (ARKG) Moves Investors should Listen - Stock Traders Daily
Cathie Wood Buys $35 Million Of Amazon, Targets Crypto; Sells $42 Million Of This Stock - MSN
Tracking Cathie Wood’s ARK Invest 13F Portfolio – Q3 2024 Update (NYSEARCA:ARKK) - Seeking Alpha
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500 - Benzinga
Cathie Wood's Sky-High Vision: Dumps Shares Of Cybercab Touting Tesla For This eVTOL Play - Yahoo Finance
Best Biotech ETFs to Watch Right Now - The Motley Fool
7 popular thematic ETFs: Here’s how to invest in some of the hottest trends - MSN
Cathie Wood Continues To Sell Shares Of Jack Dorsey's Bitcoin-Focused Company Block — Ark Also Dumps Moderna, Robinhood Stock - MSN
(ARKG) Investment Analysis - Stock Traders Daily
Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table - Yahoo Finance
Interest Rate Regimes And ARKG: Underperformance Explained (BATS:ARKG) - Seeking Alpha
ARK Genomic Revolution ETF (BATS:ARKG) Shares Sold by Capital Market Strategies LLC - Defense World
Learn to Evaluate (ARKG) using the Charts - Stock Traders Daily
ARK Invest teams up with eToro to launch portfolio of ETFs - ETF Stream
ARK Invest Teams Up With eToro to Debut Portfolio of ETFs - Yahoo Finance
Cathie Wood's Ark Invest Dumps Palantir Shares Amidst S&P 500 Inclusion And Extended AI Alliance - Benzinga
(ARKG) Proactive Strategies - Stock Traders Daily
Bridges Investment Management Inc. Has $332,000 Stock Holdings in ARK Genomic Revolution ETF (BATS:ARKG) - Defense World
Forget Quantum-Si Stock, Olink Acquirer Thermo Fisher Is a Better Long-Term Investment - MSN
Top ETFs Tracking CRISPR Gene Editing - The Motley Fool
Made-in-America Industrial Bets Are Dethroning the Likes of ARKK - Wealth Management
In the age of new tech, old-economy industrial bets still thriving - Financial Post
In Age of New Tech, Old-Economy Industrial Bets Still Thriving (ARKK, PAVE) - Bloomberg
How Rich Is Cathie Wood? What To Know About the Famed Stock Picker and ARK Invest CEO - MSN
908 Devices: Key Investor Now Selling (NASDAQ:MASS) - Seeking Alpha
Cathie Wood's Stock Shuffle: 1 Stock She's Loving, 1 She's Leaving - 24/7 Wall St.
ARK Genomic Revolution ETF (ARKG) 財務データ
ARK Genomic Revolution ETF (ARKG) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.73%
大文字化:
|
ボリューム (24 時間):